Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Androgen Modulation of Response to Selective Phosphodiesterase Inhibitors in Erectile Dysfunction

NCT00512707 is registered in ClinicalTrials.gov with Boston University as lead sponsor.

NCT NCT00512707
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00512707 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Androgen Modulation of Response to Selective Phosphodiesterase Inhibitors in Erectile Dysfunction
Lead sponsor
Boston University
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2006
Completion date
May 31, 2010
Enrollment
140 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, erectile dysfunction, testosterone deficiency